ARTICLE | Company News
AltaRex Corp., United Therapeutics deal
August 18, 2003 7:00 AM UTC
The companies expanded an April deal under which UTHR received an exclusive license from AXO to develop and commercialize five antibodies to treat various cancers (see BioCentury, April 22). As expand...